I've been busy these last few days in adding a
couple of Yahoo aliases to congratulate myself with my
own posts and sharp foresight on this board. But I
see that it did not help in wising up the dumbos.
Dumbos? Who are the dumbos? Well, in this post I will use
the term 'dumbos' to refer to the longs, of course.
Because who's been losing his/her shirt these last few
months? Well, yeah, it's been the longs. The
self-proclaimed super-smart in-the-know ivory-tower PhD crowd.
Yeah. They had some problems interpreting a news
release recently, but that's because they're very nervous
these days. The margin calls started coming in. The
post-graduates had gone a little too long on INCY at bargain
basement $40 prices. It was supposed to have been a
'bottom'. Then $30. It was a bottom, too. Then $25. Another
Now $21. Yep. These people are Real Smart.
It's been clear for some time that those who think
they are very clever indeed have, in fact, no clue
when it comes to investing. You don't wonder why INCY
fails to deliver with that kind of PhDs.
PhD's again believe that the low, low stock price means
that we have an article on sale here! So there we go
In at $20, out at 12 1/2. Isn't it sad?
Yes, it's sad. Very sad.
But I'll try to
explain it one more time for those lucky enough to still
be on the right side of the buying
Look guys, this company is making products that are
being phased out. In three years nobody will think of
INCY databases. In addition, INCY's pathetic patent
portfolio that is promising unlimited profits according to
the dumbos, is, in fact, falling apart even before
they've earned a dime from it. Or before they've had to
defend it in court. Even worse, the competition has more
money to spend, does a better job at PR and in general,
has credibility that blows away the fraud-invested
millionaire clowns that continue to successfully misguide the
last few remaining INCY longs into believing that they
are working for the investor. Barring the dumbos the
entire world understands these crooks by now. They've
been lining their pockets with investor money. Now the
world is dumping this company. Soon the leeches will
jump and will start another biotech fraud. And don't
worry, Alex Brown and Hamquist are already lining up as
sponsors to squeeze some more dollars out of that juicy
investor community. But first they will have to downgrade
INCY to hell.
Stong Buy!!!! Yeah right. Check your
brain first, then fork over your hard-earned money to
these white-board criminals.
Today, nobody wants
to own paper in a company that is sucking millions
of dollars of cash to duplicate public-domain
efforts. (In fact, that's what they claim they are doing -
but we don't really know if they are actually doing
it. Millions of dollars might be ending up in very
Nobody wants to invest in an outfit
that promises, then promises some more, then changes
promises, then changes strategy, then delivers nothing.
Except, of course, the dumbos.
In truth, I feel
sorry for those that bought high. Buying high and
selling low is not good. But it's still better to buy
high and sell low than buy high and face Chapter 11.
So get out today because it may well be your last
chance at this price.
Don't believe me? No problem.
Just hold and wait.
After all, it's your
Incyte is not too strong on the PR site. I hope
it will get better� I am loosing a lot of money on
Incyte and do not understand why the stock is going
Incyte has a number of good products and many talented
people to move it forward.
1. Incyte databases have a
lot of value (some day the royalties will be coming
2. Incyte/Synteni Microarrays is a proven technology
that many Pharmaceuticals are committed to. Incyte
clones on Synteni chips is a valuable proposition.
Incyte has the most powerfull data center and
bioinformatics in the industry.
4. Incyte sequencing
facilities are outstanding and should allow them to sequence
Genome a head of the competition. I believe they are
also doing a lot of contract sequencing, etc.
Incyte also owns Genome Systems (Consumer Genomics) and
I do not understand why Incyte stock is
so low. It should be at least at $40 based on the
competition stock prices and probably even higher since the
integrated solution should have the higher value.
of Suckerally or anyone else. You're pissed
because he is absolutely correct and his posts are both
witty and informative. Ergo, readers look for him.
Yours, however, are to be shunned. They are boring,
bitter and almost always wrong--about everything. Do
yourself a favor, read Suckerally's posts and learn from
them. Or, even better, just don't post. You're
Says who a court ruled in favour of PKN? I didn't
see any press release and Nycomed's stock has not
fallen. I thought Amersham would beat Perkin Elmer based
on the dying patent for their sequencer. Maybe I am
wrong. I am wrong so much I own Perkin Elmer and Nycomed
stock (and Incyte and Human Genome and a ton of
others). Go genomics in general and Incyte in
PS. Didn't we beat expectations with those earnings?
There was good revenue growth as well. This is one hell
of a dog of late. I have a friend who works there
and they are not worried from a business perspective,
but Wall Street does look too fondly on Incyte these
See news - INCY downgraded. Obviously, beating
earnings isn't the focus of the earnings report. Long term
legal battles will keep this stock down for quite some
time. Suckerally is absolutely right - there's better
ways to make money than to philosophize about the
potential of a company.
Why should he say anything nice about the
company? He does not hold the stock, he is short the
stock, and although he has as much vested interest in
the success of the company as you do, the nature of
this interest is quite a bit different.
Several days ago, a court ruled in favor of
Perkin Elmer on a patent infringement lawsuit against
Amersham. As you know, INCY is heavily invested in the
MegaBace sequencing system. Will this ruling adversely
effect the ability of Amersham to support the MegaBace
hardware already in place?? Is an injunction likely to
follow?? Do the consequences of this decision have the
potential to adversely effect the seqencing operations of
INCY?? At the very least if would appear that INCY
placed it's bet on the wrong horse.
Suckerally. As often as I have read these posts,
I don't think I have ever heard you say anything
good about this company. Why then do you hold shares
of it's stock? If it really is such an awful
investment why don't you dump? Just curious? Or is it maybe
that in the long run you feel that the company has a
good future outlook and you don't want to miss the